Pregnancy rate · women trying to conceive by intrauterine insemination
Short interval may leads to lower pregnancy rate per couple ‐ 24 hours versus 34 to 36 hours compared with long interval (low certainty).
3 findings from 1 review
OR 0.55 [0.31, 0.98]
2 studies · 234 participants
Low
OR 0.44 [0.1, 1.92]
1 study · 30 participants
Low
OR 0.58 [0.14, 2.48]
1 study · 30 participants
Low
Miscarriage · women trying to conceive by intrauterine insemination
It is very uncertain whether short interval changes miscarriage rate per pregnancy ‐ 24 hours versus 34 to 36 hours compared with long interval (very low certainty).
3 findings from 1 review
OR 1.58 [0.35, 7.16]
2 studies · 67 participants
Very low
OR 4 [0.27, 58.56]
1 study · 15 participants
Very low
OR 1.33 [0.07, 25.91]
1 study · 16 participants
Very low
Live birth rate per couple · women trying to conceive by intrauterine insemination
Short interval showed no clear difference in live birth rate per couple ‐ 24 hours versus 34 to 36 hours compared with long interval (low certainty).
1 finding from 1 review
Days taken to achieve full feeding · preterm infants less than 1500 grams
1 finding from 1 review
Days to regain birth weight · preterm infants less than 1500 grams
1 finding from 1 review
Length of hospital stay · preterm infants less than 1500 grams
1 finding from 1 review
Necrotising enterocolitis · preterm infants less than 1500 grams
Short feeding interval showed no clear difference in necrotising enterocolitis compared with long feeding interval (low certainty).
1 finding from 1 review
Rate of weight gain (g/kg/day) · preterm infants less than 1500 grams
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Catheter‐related blood stream infection · patients with a central venous catheter
Longer intervals (5‐15 days) (intervention) showed no clear difference in catheter‐related blood stream infection (CRBSI) compared with shorter intervals (2‐5 days) (control) between dressing changes (low certainty).
1 finding from 1 review
RR 1.42 [0.4, 4.98]
Studies not reported
Low
All‐cause mortality · patients with a central venous catheter
Longer intervals (5‐15 days) (intervention) showed no clear difference in all‐cause mortality compared with shorter intervals (2‐5 days) (control) between dressing changes (low certainty).
1 finding from 1 review
RR 1.06 [0.9, 1.25]
Studies not reported
Low
Skin damage № of participants: 1587 (4 RCTs) · patients with a central venous catheter
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Pain № of participants: 193 (2 RCTs) · patients with a central venous catheter
Longer intervals (5‐15 days) (intervention) showed no clear difference in pain № of participants: 193 (2 RCTs) compared with shorter intervals (2‐5 days) (control) between dressing changes (low certainty).
1 finding from 1 review
RR 0.8 [0.46, 1.38]
Studies not reported
Low
Antibody response (geometric mean titre) · 9‐ to 14‐year‐old females and males
1 finding from 1 review
Invasive cervical, vaginal, vulval, anal, or penile cancer · 9‐ to 14‐year‐old females and males
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
High‐grade cervical, vulval, vaginal, penile, or anal intraepithelial neoplasia · 9‐ to 14‐year‐old females and males
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall local/injection site adverse events · 9‐ to 14‐year‐old females and males
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall systemic events and general symptoms · 9‐ to 14‐year‐old females and males
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events at up to 5‐year · 9‐ to 14‐year‐old females and males
It is very uncertain whether two doses of HPV vaccine with longer interval changes serious adverse events at up to 5‐year compared with two doses of HPV vaccine with shorter interval (very low certainty).
1 finding from 1 review
Mortality at up to 5‐year · 9‐ to 14‐year‐old females and males
1 finding from 1 review
Clinical and harms outcomes* · 9‐ to 14‐year‐old females and males
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found